Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive-Behavioural Treatment for Generalized Anxiety Disorder: Impact of Cognitive Processing on Short- and Long-Term Outcomes

NCT03099772 is registered in ClinicalTrials.gov with Concordia University, Montreal as lead sponsor.

NCT NCT03099772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03099772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive-Behavioural Treatment for Generalized Anxiety Disorder: Impact of Cognitive Processing on Short- and Long-Term Outcomes
Lead sponsor
Concordia University, Montreal
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2007
Completion date
March 31, 2012
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder